CLINICAL TRIALS PROFILE FOR PRINIVIL
✉ Email this page to a colleague
All Clinical Trials for PRINIVIL
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00459056 ↗ | The Vascular Effects of Carvedilol Controlled Release (CR) in Abdominally Obese Hypertensive Patients | Completed | GlaxoSmithKline | Phase 3 | 2007-04-01 | The purpose of this study is to compare the effects of two different combination therapies for high blood pressure on vascular health. |
| NCT00459056 ↗ | The Vascular Effects of Carvedilol Controlled Release (CR) in Abdominally Obese Hypertensive Patients | Completed | St. Paul Heart Clinic | Phase 3 | 2007-04-01 | The purpose of this study is to compare the effects of two different combination therapies for high blood pressure on vascular health. |
| NCT00605072 ↗ | The Antihypertensives and Vascular, Endothelial and Cognitive Function Trial | Completed | Hebrew SeniorLife | Phase 2 | 2008-01-01 | The purpose of this study is to examine the effects of blood pressure medications on cognition and blood flow in hypertensive elderly patients with cognitive impairment. The hypothesis is that treatment with an angiotensin receptor blocker (ARB) or an angiotensin-converting enzyme inhibitor (ACEI) will be associated with a slower rate of further cognitive decline, improved cerebral blood flow and its regulation, and preserved physical function as compared to treatment with a diuretic (HCTZ), independent of blood pressure level. |
| NCT00605072 ↗ | The Antihypertensives and Vascular, Endothelial and Cognitive Function Trial | Completed | National Institute on Aging (NIA) | Phase 2 | 2008-01-01 | The purpose of this study is to examine the effects of blood pressure medications on cognition and blood flow in hypertensive elderly patients with cognitive impairment. The hypothesis is that treatment with an angiotensin receptor blocker (ARB) or an angiotensin-converting enzyme inhibitor (ACEI) will be associated with a slower rate of further cognitive decline, improved cerebral blood flow and its regulation, and preserved physical function as compared to treatment with a diuretic (HCTZ), independent of blood pressure level. |
| NCT00605072 ↗ | The Antihypertensives and Vascular, Endothelial and Cognitive Function Trial | Completed | University of Southern California | Phase 2 | 2008-01-01 | The purpose of this study is to examine the effects of blood pressure medications on cognition and blood flow in hypertensive elderly patients with cognitive impairment. The hypothesis is that treatment with an angiotensin receptor blocker (ARB) or an angiotensin-converting enzyme inhibitor (ACEI) will be associated with a slower rate of further cognitive decline, improved cerebral blood flow and its regulation, and preserved physical function as compared to treatment with a diuretic (HCTZ), independent of blood pressure level. |
| NCT01234922 ↗ | Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors | Terminated | Comprehensive Cancer Center of Wake Forest University | Phase 2 | 2011-02-01 | RATIONALE: Benazepril hydrochloride, lisinopril, ramipril, and losartan potassium may help lower blood pressure. PURPOSE: This phase II trial is studying how well benazepril hydrochloride, lisinopril, ramipril, or losartan potassium works in treating hypertension in patients with solid tumors. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for PRINIVIL
Condition Name
Clinical Trial Locations for PRINIVIL
Trials by Country
Clinical Trial Progress for PRINIVIL
Clinical Trial Phase
Clinical Trial Sponsors for PRINIVIL
Sponsor Name
